Edwards Lifesciences (EW) Revenue and Net Income History

Historical revenue, operating income and net income for Edwards Lifesciences (EW) over the last 10 years. The current TTM revenue for Edwards Lifesciences as of June 18, 2018 is $3.44B.

Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $32.146B $3.435B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.